Xingyu Wu

1.5k citations
67 papers · 953 indexed · h-index 19
Topics
Cancer-related gene regulation (7 papers)RNA modifications and cancer (6 papers)Cancer-related Molecular Pathways (5 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xingyu Wu

61 papers receiving 947 citations

Peers

Xingyu Wu
Comparison fields: 5 of 103
  • Molecular Biology 493
  • Cancer Research 213
  • Oncology 164
  • Pulmonary and Respiratory Medicine 126
  • Epidemiology 76
Replace Qiong Zou with:
Qiong Zou China
Panagiotis Katsonis United States
Chung‐Ping Hsu Taiwan
Shaobo Zhang United States
Nitin Chakravarti United States
Shreeram C. Nallar United States
Changyou Li United States
Natacha Rocks Belgium
Chiao‐Fang Teng Taiwan
Zhenyu Xu China
Xingyu Wu relative to Qiong Zou China Qiong Zou's profile →
Citations per field
00.5×
Qiong Zou · 1×
Citations per year

Countries citing papers authored by Xingyu Wu

Since Specialization
Citations

This map shows the geographic impact of Xingyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyu Wu more than expected).

Fields of papers citing papers by Xingyu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyu Wu. The network helps show where Xingyu Wu may publish in the future.

Co-authorship network of co-authors of Xingyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyu Wu. A scholar is included among the top collaborators of Xingyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyu Wu. Xingyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 6
4 2
5 8
6 3
7 1
8 1
9 54
10 24
11 1
12 1
13 43
14 15
15 54
16 67
17 87
18 20
19
Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase.
2
20 5

About Xingyu Wu

Xingyu Wu is a scholar working on Cancer Research, Molecular Medicine and Endocrinology, having authored 67 papers that have together received 953 indexed citations. Recurring topics across this work include Cancer-related gene regulation (7 papers), RNA modifications and cancer (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (213 citations), Molecular Medicine (52 citations) and Molecular Biology (493 citations). Xingyu Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include J. Silvio Gutkind, Scott M. Lippman, Zhiyong Wang, Qianming Chen, Ridong Li, Zemei Ge, Runtao Li, Zhenming Liu, Li Zuo and Xianling Ning. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026